Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Kristi Reynolds, PhD

Research Scientist
Kaiser Permanente Southern California

Disclosure(s): Amgen: Grant/Research Support; Dynavax: Grant/Research Support; Merck: Grant/Research Support; Novartis: Grant/Research Support

Poster(s):

115 - Post-licensure Safety Study of New-onset Immune-mediated Diseases, Herpes Zoster, and Anaphylaxis in Adult Recipients of HepB-CPG Vaccine Versus HepB-alum Vaccine
Thursday, October 20, 2022
12:15 PM – 1:30 PM US ET